title: Sexually transmitted diseases.
abstract: Sexually transmitted diseases (STDs) continue to be a global epidemic with significant risk of morbidity/mortality for the fetus. STDs with prominent cutaneous findings including condylomata acuminata, genital herpes infections, and syphilis are reviewed. Important clinical cutaneous findings help aid early diagnosis and facilitate treatment. Condylomata acuminata have the potential of causing cervical cancer, anogenital cancer, and oropharyngeal cancer. Significant advances have been made in human papilloma virus vaccinations and treatment. Genital herpes infection can produce significant physical and emotional distress to the patient and significant potential harm to the fetus. Early clinical recognition of STDs and their appropriate management is critical.
authors.affiliation: *Division of Dermatology, Departments of Dermatology †Obstetrics and Gynecology, Ohio State University College of Medicine, Gahanna, Ohio.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Bechtel
authors.forename: Wayne
authors.initials: W
authors.lastname: Trout
mesh_terms: D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D000634:Aminoquinolines / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002601:Chancre / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D003218:Condylomata Acuminata / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D005260:Female; D006558:Herpes Genitalis / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D000077271:Imiquimod; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D010406:Penicillins / Q000627:therapeutic use; D011034:Podophyllotoxin / Q000627:therapeutic use; D012749:Sexually Transmitted Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D013591:Syphilis, Cutaneous / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000634:Aminoquinolines; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D053918:Papillomavirus Vaccines; D010406:Penicillins; D014633:Valine; D011034:Podophyllotoxin; D000077483:Valacyclovir; D000077271:Imiquimod; D000212:Acyclovir